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Received 17 July 2010; received in revised form 21 September 2010; accepted 21 September 2010Abstract Mouse embryonic fibroblasts (MEFs) are the most commonly used feeder cells for pluripotent stem cells. However,
autogeneic feeder (AF) cells have several advantages such as no xenogeneic risks and reduced costs. In this report, we
demonstrate that common marmoset embryonic stem (cmES) cells can be maintained on common marmoset AF (cmAF) cells.
These cmES cells were maintained on cmAF cells for 6 months, retaining their morphology, normal karyotype, and expression
patterns for the pluripotent markers Oct-3/4, Nanog, SSEA-3, SSEA-4, TRA-1-60, and TRA-1-81, as well as their ability to
differentiate into cardiac and neural cells. Antibody array analysis revealed equivalent protein expression profiles between
cmES cells maintained on cmAF cells and MEFs. In addition, similarly prepared human embryonic stem (hES) and induced
pluripotent stem (hiPS) cell-derived AF cells supported the growth of and maintained the morphology and pluripotent marker
expressions of hES and hiPS cells, respectively. DNA microarray analysis revealed that these hES and hiPS cells had mRNA
expression profiles similar to those of hES and hiPS cells maintained on MEFs, respectively. Taken together, these findings imply
that AF cells can replace MEFs in the routine maintenance of primate pluripotent stem cells.
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Since human embryonic stem (hES) cells were first established
by Thomson et al. in 1998, promising results have been
obtained with these cells (Thomson et al., 1998). However,
owing to ethical problems and concerns about clinical safety,
hES cells have not yet been used in clinical studies. Nonhuman
primates and their ES and induced pluripotent stem (iPS) cells
are expected to be effective preclinical models given their
close genetic relationships to humans, as compared with.
84 W. Li et al.rodents (Hearn, 2001; Nakatsuji and Suemori, 2002). Sasaki
and co-workers recently established common marmoset ES
(cmES) and iPS cell lines, and green fluorescent protein (GFP)-
transgenic marmosets (Sasaki et al., 2005; Sasaki et al., 2009;
Tomioka et al., 2010), and described the efficient differenti-
ation of neural cells from cmES cells (Sasaki et al., 2005). Chen
et al. also reported successful differentiation of cardiomyo-
cytes from cmES cells and described their characterization
(Chen et al., 2008).
Recently, iPS cells have been established in rodents
(Takahashi and Yamanaka, 2006), nonhumanprimates (Tomioka
et al., 2010; Wu et al., 2010; Liu et al., 2008), and humans
(Takahashi et al., 2007). Clinical applications for these cells are
also eagerly awaited, since iPS cells with a genetic background
identical to that of the patient can be generated with less
ethical concerns. Even though several improvements have been
made to combat initial problems, clinical application of human
iPS (hiPS) cells is still controversial due to a number of safety
concerns.
Common technical constraints for the therapeutic applica-
tion of hES and hiPS cells also remain. One such limitation is
avoiding the use of xenogeneic materials, since there is a risk of
cross-transfer of potential pathogens and unexpected genes. To
date, various xenogeneic factor-freeculturemethodshavebeen
developed to replace the MEFs used for culturing hES cells, such
as immortalized MEFs (Choo et al., 2006), Matrigel (Xu et al.,
2001; Akopian et al., 2010), mixed extracellular matrix (Amit
and Itskovitz-Eldor, 2006), human-derived primary (Cheng et
al., 2003; Lee et al., 2005) and immortalized feeder cells (Unger
et al., 2009), suspension culture systems (Steiner et al., 2010;
Singh et al., 2010; Olmer et al., 2010; Amit et al., 2010), and
autogeneic feeder (AF) cells (Amit and Itskovitz-Eldor, 2006;
Choo et al., 2008; Stojkovic et al., 2005; Wang et al., 2005), as
well as several xenogeneic factor-free media (Akopian et al.,
2010) which can be combined with xeno-free feeders and
feeder-free methods. Nevertheless as shown in the report from
the International Stem Cell Initiative, most xenogeneic factor-
free culture systems based on feeder-free conditions are biased
toward hES cell lines (Akopian et al., 2010), suggesting that the
MEF feeder system remains the standard because it ensures
stable and reliable maintenance for every pluripotent stem cell
line. Also in our hands, the MEF feeder system is still the most
reliable and generalmethod formaintaining cmES and hES cells,
and hiPS cells. Therefore, it is necessary to develop further
options for alternative human feeder cells.
AF systems for hES cells have been reported by two groups;
the first group derivedAF cells via embryoid body (EB) formation
(Stojkovic et al., 2005), while the second group generated a
stable cell line from differentiated hES cells (Choo et al., 2008).
In the present report, we describe a novel method for the
preparation of AF cells derived from spontaneously differenti-
atedcells for use in the routinemaintenance of pluripotent stem
cells. In addition, we report a common method for the
preparation of AF cells for different nonhuman primate and
human pluripotent stem cells.Results
Under our routine experimental conditions, cmES, hES, and
hiPS cells stably self-renew on MEFs. However a small
fraction of each colony contains spontaneously differentiat-ed cells that have sprouted from the edges of the colonies.
During routine passaging, we found that the weak trypsin and
collagenase treatment detached preferentially the undiffer-
entiated cells of the colonies, leaving the differentiated cells
attached to the plate (Fig. 1a). Since the detached cells had
features typical of fibroblasts, we expected that they could
be used as AF cells. Previously, these cells would have been
discarded, so we term our AF preparation the “cell recycling
system.” The principle underlying this phenomenon is shown
in Fig. 1b.
We cultured the residual cells for 2–4 weeks until they
reached subconfluence. The cultivation period to the first
passage varied depending on the initial concentration of
differentiated cells. The period of time between the passages
was approximately 3–5 days. Between the first and third
passages, we estimated that the cells had a doubling time of
about 20 h. To investigate the relationship between passage
number and ability to maintain the undifferentiated state of
the cmES cells, we seeded cmES cell clumps ontomitomycin C-
treated cmAF cells of various passage numbers, and observed
themorphology of the cells under themicroscope (Fig. 1c).We
found that the cmAF cells that underwent up to three passages
maintained the cmES cells without any obvious morphologic
alteration of the cmES cells (Fig. 1c). In contrast, when we
used cmAF cells after the fourth passage, we found a
significant decrease in their maintenance capability. There-
fore, we used cmAF cells at the third passage for routine
culturing of cmES cells. cmAF cells that were freshly treated
with mitomycin C could maintain cmES cells for 1 week;
thereafter, they showed decreased viability and maintenance
ability. To investigate whether residual MEFs were diluted
during cmAF expansion, we performed immunohistochemical
analysis for human nuclear antigen (Chen et al., 2008) on
cultures of cmAF cells. We found no human nuclear antigen-
negative cells (residual MEFs) by fluorescent microscopy
(Fig. 1d), which meant that the MEFs had been eliminated
during the three passages. The mitomycin C-treated and
untreated cmAF cells were successfully stored in the long-term
using slow-freezing methods. The viability of the recovered
cmAF cells was typically 80 to 90%.
We prepared consecutive batches of cmAF cells from cmES
cells that had been cultured on cmAF cells, and maintained the
cmES cells in this system formore than 6 months. The cmES cells
cultured on cmAF cells for 6 months expressed Oct-3/4, Nanog,
SSEA-3, SSEA-4, TRA-1-60, and TRA-1-81 (Fig. 2a). We also
confirmed that the cmES cells possessed alkaline phosphatase
activity, which is a typical feature of pluripotent stem cells
(Fig. 2a). Cytogenetic analysis of the cmES cells that were long-
term-cultured on cmAF cells revealed that they retained the
normal karyotype of 46XX (Fig. 2b).
To investigate the differentiation ability of the cmES cells
cultured on cmAF cells, we induced cardiogenic and neurogenic
differentiation. The cmES cells differentiated into cardiomyo-
cytes via embryoid body formation (Fig. 3a). We partially
dispersed the EBs and attached them to fibronectin-coated
dishes. Immunohistochemical analysis revealed that the EBs
expressed Nkx2.5 and sarcomericα-actinin, indicating that they
were cardiomyocytes (Fig. 3b, left panel). We induced
neurogenic differentiation by serum withdrawal and retinoic
acid stimulation. Thus, we observed sprouting filamentous cells
from the attached core of the EBs (Fig. 3b, right panel). We
demonstrated immunofluorescence staining for βIII tubulin,
Figure 1 Preparation and application of cmAF cells to cmES cell culturing. (a) Spontaneously differentiated cells that remain on the
culture dish are expanded. (b) Schematic representation of the preparation of cmAF cells and the culturing of cmES cells.
(c) Morphology of cmES cells cultured on either MEFs (left) or cmAF cells (right). (d) Absence of MEF contamination in the cmAF cells
(p3). The right panel shows MEFs used as a negative control in the immunohistochemical detection of human nuclear antigen (hNA).
Scale bars: (a and c) 500 μm; (d) 200 μm.
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of the cells expressed βIII tubulin.
Furthermore, todemonstrate the similarity of cmAFcells and
MEFs, we analyzed the protein expression profiles of cmES cells
cultured on cmAF cells and MEFs, taking advantage of antibody
(protein) arrays that are applicable to a broad range of species
from rodents to humans. We used the Panorama antibody
microarray XP725 kit, which consists of 725 antibodies that have
been validated by the manufacturer for studies of mouse and
human samples. These antibodies represent families of proteins
known to be involved in a variety of important biological
pathways, including cell signaling, matrix processing, cell
growth, and apoptosis. We analyzed Cy3 labeling of the total
protein extracts fromcmES cells cultured on cmAF cells orMEFs.
Each Cy3-labeled protein was bound to an individual antibody-
arrayed glass slide. The fluorescent signalswere evaluated using
a scanner (Fig. 3c, left). Few proteins had greater than twofold
expression changes between cmES cells cultured on cmAF cells
and MEFs, indicating that cmES cells cultured on cmAF cells and
MEFs have similar protein expression profiles (Fig. 3c, right).We
also compared cmES cells cultured on cmAF cells with purified
common marmoset ES cell-derived cardiomyocytes as a control
experiment. Several differences in protein expression were
observed between the cmES cells and purified cardiomyocytes;
these included proteins reported to be expressed in cardiomyo-
cytes, such as histone deacetylase 2 (Lu and Yang, 2009),
estrogen receptor, and in pluripotent stem cells, such as
mitogen and stress activated kinase (Arthur and Cohen, 2000),
C-src tyrosine kinase, and Coffilin (Fig. 3d).
Next, we applied our feeder preparation method to hES and
hiPS cells (Fig. 4). The hAF and hiAF cells prepared from hES andhiPS cells were found to maintain hES and hiPS cells for more
than 2 months, respectively (Fig. 4a). To investigate whether
the MEFs were diluted during the expansion of hiAF cells, we
performed immunofluorescent staining for human nuclear
antigens with analysis by FACS. Almost all the prepared hiAF
cells were positive for human nuclear antigen (Fig. 4b). To
further investigate whether the MEFs were diluted during the
expansion of hAF cells, we used a stably GFP-expressing hES cell
line for hAF cell preparation. We randomly observed five visual
fields under the microscope. As a result, no GFP-negative cells
(MEFs) were found in the prepared hAF cells (Supplementary
Fig. 2). Taken together, these findings show that residual MEFs
are eliminated in hiAF cells. Next, we investigated the
pluripotency of hiPS cells maintained on hiAF cells by
immunofluorescent stainings including microscopic observation
(Supplementary Fig. 3) and FACS analysis of SSEA-4, TRA-1-81,
Nanog, andOct-3/4, and confirmed that almost all the hiPS cells
expressed the four pluripotent markers (Fig. 4c). We also
performed DNA expression array analysis of the hES and hiPS
cells that were maintained long-term on hAF and hiAF cells,
respectively. Equivalent mRNA expression levels of the plur-
ipotency-related genes including oct-3/4, nanog, sox-2, lin28,
and c-mycwere observed. Global gene expression profiles were
also quite similar in both cases (Fig. 4d, left). In contrast, two
comparative expression profiles between hES and hiPS cells and
their differentiating EBs indicated the marked existence of
differentially expressed genes (Fig. 4d, right). In addition, a
similar magnitude of difference to the results shown in the left
panel of Fig. 4d was seen when comparing global gene
expression profiles for hES and hiPS cells during different
passage numbers (Supplementary Fig. 4). All these results show
Figure 2 Pluripotent marker expression and cytogenetic
analyses of cmES cells cultured on cmAF cells. (a) Immunoflu-
orescence staining for Oct-3/4, Nanog, SSEA-3, SSEA-4, TRA-1-
30, and TRA-1-80 of cmES cells cultured on cmAF cells for
6 months. Alkaline phosphatase activities of cmES cells cultured
on either cmAF cells (left panel) or MEFs (right panel).
(b) Cytogenetic analysis of cmES cells cultured on cmAF cells
for 6 months. Scale bar: (a) 300 μm.
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undifferentiated state and in a condition quite similar to that
achieved with MEFs.Discussion
We have demonstrated the preparation of AF cells from three
different cell sources using a commonmethod. These AF cells
succeeded in effectively maintaining their pluripotent stem
cells.
In this study,weused antibody array analyses to characterize
cmES cells. Quite similar protein expression profiles were
observed between cmES cells cultured on cmAF cells and
MEFs. However, in contrast, various differentially expressed
proteins were observed in purified cmES cell-derived cardio-
myocytes compared to cmES cells. These results validate the
usefulness of this system, and indicate a similar efficacy of cmAF
cells compared to MEFs for the maintenance of cmES cells. The
mRNA expression profiles produced by global gene array
analyses comparing hES cells cultured on hAF cells and MEFs
andhiPS cells culturedonhiAF cells andMEFs revealedanoverall
high similarity in profiles; however, they were not perfectly
identical. The differential gene expression profiles comparing
different passage numbers of the same human pluripotent stem
cells maintained with the same feeder cells showed a similar
dispersion to those observed between human pluripotent stem
cells maintained with MEF and AF cells. These results suggest
that some allowable gene expression changes might spontane-
ously occur during long-term culture in pluripotent stem cells,
although the genes related with pluripotency must be
maintained.
Using our routine preparation of cmAF cells, approximately
1×108 cells can be obtained from a single 10-cm dish and three
cell passages. This number of cmAF cells is sufficient to prepare
100 10-cm dishes for cmES cell culturing. In contrast, 1×107
MEFs are typically obtained from a single mouse embryo under
our experimental conditions. Thuswebelieve that ourAF system
has a comparable cell yield to that of the MEF system.
As potential therapies using personalized iPS cells become
possible, it may be reasonable to maintain an individual's hiPS
cell line using their AF cells, because therewould be no concerns
of transfer of allogenic antigens or infectious viruses from the
feeder cells. Even in the case of mass production of therapeutic
cells from banked pluripotent stem cells, techniques have not
yet been established for maintaining pluripotent stem cells
under xenogeneic factor-free conditions at a reasonable cost.
Conclusions
The present study establishes an effectivemethod for preparing
AF cells which is applicable to cmES, hES, and hiPS cells. We
believe that the results of the present studypave theway for the
reliable and economic production of alternative feeder cells for
pluripotent stem cells.
Materials and methods
Maintenance of undifferentiated cmES, hES cells,
and hiPS cells
The cmES cells (cell line No. 20; Central Institute of
Experimental Animals, Kawasaki, Japan), hES cells (khES-2;
Institute for Integrated Cell-Material Sciences, Kyoto Universi-
ty), and hiPS cells (G4; Center for iPS Cell Research and
Figure 3 In vitro differentiation abilities of the cultured cmES cells and antibody array analysis of cmES cells cultured on either
cmAF cells or MEFs. (a) EB formation of cmES cells during long-term culturing on cmAF cells. (b) Cardiomyocytes and neurons
differentiate from cmES cells during long-term culturing on cmAF cells. (c) Antibody array analysis was performed on Cy3-labeled total
protein extracts from cmES cells cultured on either cmAF cells or MEFs for 50 days. The left panels show the raw images of the Cy3
signals. The scatter plot shows the relative fluorescence levels for the antibodies used to stain cmES cells cultured on cmAF cells (y-
axis) and MEFs (x-axis). (d) Antibody array analysis was performed on protein extracts from cmES cells cultured on cmAF cells and
purified cmES cell-derived cardiomyocytes. The scatter plot shows the relative fluorescence levels for the antibodies used to stain
purified cmES cell-derived cardiomyocytes (y-axis) and cmES cells cultured on cmAF cells (x-axis). Twofold differences, representing
the threshold in this experiment, are indicated as lines in the plots (c, d). Scale bars: (a) 300 μm; (b) 100 μm.
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Kyoto University) were maintained as described previously
(Chen et al., 2008; Hattori et al., 2010). Briefly, cmES cells were
maintained on feeder cells in cmES cell medium, which
consisted of 80% Knockout Dulbecco's modified Eagle's medium
(KO-DMEM; Invitrogen, Carlsbad, CA, USA), 20% Knockout Serum
Replacement (KSR; Invitrogen), 0.1 mM nonessential amino
acids (Sigma Chemical Company), 2 mM L-glutamine (Sigma, St.
Louis, MO), 0.1 mM β-mercaptoethanol (Sigma), and 4 ng/mL
basic fibroblast growth factor (Wako Pure Chemical Industries,
Osaka, Japan). hES and hiPS cells were similarly maintained,
except that Dulbecco's modified Eagle's medium/Nutrient
Mixture F-12 Ham's (1/1 ratio, DMEM-F12; Sigma) was used
instead of KO-DMEM. The cmES and hES cells were passaged
every 5–7 days. Typically, we cultured pluripotent stem cells in
15-cm dishes (Becton–Dickinson, NJ, USA). Using this method,
all reagent amounts were suitable for 15-cm dish cultures.Passage of pluripotent stem cells
All cmES, hES, and hiPS cells were treated with 2 mL of 0.25%
trypsin (Becton–Dickinson), 0.1% collagenase type 3 (Worthing-
ton Biochemical Corp., NJ, USA), 20% KSR, and 1 mM CaCl2 in
phosphate-buffered salineat 37 °C for 5–15 min,which resultedin disruption of the boundaries between the pluripotent stem
cells and the feeder cells. Then, 5 mL of DMEM supplemented
with 10% fetal bovine serum (FBS; Biowest, FL, USA) was added
and the cells were gently pipetted several times, which
detached all the pluripotent stem cell colonies and most of
the feeder cells from the dish. The cells were separated into
three fractions by size, b40 μm, between 40 and 100 μm, and
N100 μm, using cell strainers with mesh pore diameters of 40
and 100 μm (Becton–Dickinson). These procedures are illustrat-
ed in Supplementary Fig. 1a. This process eliminated feeder
cells (Supplementary Fig. 1b). The collected pluripotent stem
cell colonies of the correct size (larger than 40 μm and smaller
than 100 μm) were seeded onto a new plate with feeder cells.Preparation of AF cells
A low number of differentiating cells remained on the culture
dish after passage (Fig. 1a). These cells were the seeds of the
AF cells, and they were propagated in DMEM (Wako)
supplemented with 10% FBS. Typically, propagation to near
confluence took 10–15 days for cmAF cells and 20–30 days for
human AF (hAF) and iAF (hiAF) cells. For passaging, the cells
were detached and dispersed by treatment with 0.25% trypsin-
EDTA solution (TE; Invitrogen) at 37 °C for 10 min. A cell
Figure 4 Application of hAF and hiAF cells to the cultivation of hES and hiPS cells, and DNA microarray analysis. (a) Morphology of
hES (upper panels) and hiPS (lower panels) cells cultured on either MEFs (left panels) or hAF and hiAF cells (right panels). (b) Human
nuclear antigen was immunofluorescently detected and analyzed by FACS (red histogram) in the hiAF cells. The negative control
(second antibody only) is shown as the blue histogram. (c) Human iPS cells which were maintained long term by hiAF cells were
passaged, as described under Materials and methods, enzymatically dispersed, immunofluorescently stained for TRA-1-81, SSEA-4,
Oct-3/4, and Nanog, and then analyzed by FACS. The negative control (second antibody only) is shown as the blue histogram. (d) DNA
microarray analysis of mRNA extracted from hES (upper left panel) and hiPS (lower left panel) cells that were cultured on either hAF
and hiAF cells (y-axis) or MEFs (x-axis) for 32 or 35 days, respectively. Similarly, comparisons between hES cells grown on hAF cells
(upper) or hiPS cells grown on hiAF cells (lower) and their EBs are shown in the right panels. The scatter plot shows the relative
expression level (threshold:10) for each gene. Twofold differences are indicated as lines in the plot. Scale bars: (a) 300 μm.
88 W. Li et al.strainer with mesh pore diameter of 40 μm (Becton-Dickinson)
was used to eliminate the residual large cell clumps (diameter
N40 μm). The purified AF cells were plated onto new 0.1%
gelatin-coated dishes that contained DMEM supplemented
with 10% FBS. For all the cmES, hES, and hiPS cells, confluence
was achieved in 3–5 days, and these cells were subsequently
passaged to the next generation using a 5-times dilution. The
second or third generation of AF cells were treatedwith 10 μg/
mL of mitomycin C at 37 °C for 3 h, and cryopreserved at
-150 °C in Cellbanker solution (Mitsubishi Chemical, Tokyo,
Japan). The cmAF, hAF, or hiAF cells recovered from the cryo-
stocks were seeded onto 0.1% gelatin-coated dishes at a
concentration of 2×106 cells per 15-cm dish.
Supplementary materials related to this article can be
found online at doi:10.1016/j.scr.2010.09.003.Acknowledgments
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